Trial · NCT02526160
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind (Placebo-Controlled) Period | STARTED | Placebo | 66 | |
| Double-Blind (Placebo-Controlled) Period | STARTED | Burosumab 1 mg/kg | 68 | |
| Double-Blind (Placebo-Controlled) Period | COMPLETED | Placebo | 66 | |
| Double-Blind (Placebo-Controlled) Period | COMPLETED | Burosumab 1 mg/kg | 67 | |
| Double-Blind (Placebo-Controlled) Period | NOT COMPLETED | Placebo | 0 | |
| Double-Blind (Placebo-Controlled) Period | NOT COMPLETED | Burosumab 1 mg/kg | 1 | |
| Open-label Treatment Continuation Period | STARTED | Placebo | 66 | |
| Open-label Treatment Continuation Period | STARTED | Burosumab 1 mg/kg | 67 | |
| Open-label Treatment Continuation Period | COMPLETED | Placebo | 63 | |
| Open-label Treatment Continuation Period | COMPLETED | Burosumab 1 mg/kg | 63 | |
| Open-label Treatment Continuation Period | NOT COMPLETED | Placebo | 3 | |
| Open-label Treatment Continuation Period | NOT COMPLETED | Burosumab 1 mg/kg | 4 | |
| Open-Label Treatment Extension Period I | STARTED | Placebo | 63 | |
| Open-Label Treatment Extension Period I | STARTED | Burosumab 1 mg/kg | 63 | |
| Open-Label Treatment Extension Period I | COMPLETED | Placebo | 60 | |
| Open-Label Treatment Extension Period I | COMPLETED | Burosumab 1 mg/kg | 59 | |
| Open-Label Treatment Extension Period I | NOT COMPLETED | Placebo | 3 | |
| Open-Label Treatment Extension Period I | NOT COMPLETED | Burosumab 1 mg/kg | 4 | |
| Open-Label Treatment Extension Period II | STARTED | Placebo | 52 | |
| Open-Label Treatment Extension Period II | STARTED | Burosumab 1 mg/kg | 49 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02526160/flow